Literature DB >> 24899441

Microneutralization assay for swine influenza virus in swine serum.

Pravina Kitikoon1, Amy L Vincent.   

Abstract

The microneutralization (MN) assay is a modification of the serum virus neutralization assay and is a serological test to detect the presence of functional systemic antibodies that prevent infectivity of virus. When infectious virus is mixed with serum antibody, the virus infectivity can be "neutralized" if the antibodies bind to blocking epitopes on the virus. The neutralization effect can be demonstrated by inoculation of susceptible cells or organisms with the antibody-virus mixture, such as cells in culture, embryonated eggs, or susceptible hosts. The results of the MN assay described here are measured based on cell culture in a microtiter plate format and a color change detected by an automated plate reader. The test is performed with a constant amount of virus and serial dilutions of serum samples to an end point where virus neutralization is no longer detected. The neutralizing antibody titer is thus the reciprocal number of the last dilution of serum with neutralizing activity. The MN assay can be used to detect antibody from pigs with natural exposure or vaccination and can potentially be used to predict cross-protection between strains of influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899441     DOI: 10.1007/978-1-4939-0758-8_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants.

Authors:  Chaonan Li; Yikai Guo; Zhongbiao Fang; Haiyan Zhang; Yanjun Zhang; Keda Chen
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

2.  The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1).

Authors:  Ahmad Tavakoli; Farhad Rezaei; Gazal Sadat Fatemi Nasab; Fatemeh Adjaminezhad-Fard; Zahra Noroozbabaei; Talat Mokhtari-Azad
Journal:  Iran J Public Health       Date:  2017-12       Impact factor: 1.429

3.  An In Vitro Microneutralization Assay for Influenza Virus Serology.

Authors:  Frans Cuevas; Hisaaki Kawabata; Florian Krammer; Juan Manuel Carreño
Journal:  Curr Protoc       Date:  2022-07

Review 4.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30

5.  Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.

Authors:  Pingping Zhang; Baisheng Li; Yao Wang; Wei Min; Xiaohui Wang; Yugui Zhou; Zhencui Li; Yong Zhao; Huan Zhang; Min Jiang; Huanying Zheng; Chao Yang; Wei Zhang; Le Zuo; Qi Gao; Zhengrong Yang; Yanzhao Li; Tiejian Feng; Changqing Lin; Qinghua Hu; Tie Song; Ruifu Yang
Journal:  BMC Microbiol       Date:  2022-02-03       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.